I wonder why all these organizations are bringing Peregrines PS Targeting MOA pipeline wonders into their organizations?? I mean all I hear is Peregrine has nadda but all I continue to see and realize that Peregrine keeps appearing here and there and everywhere
Tough to nail down when they skyrocket when they are everywhere and PS Targeting is sought after by all those that KNOW PS Targeting is required for the most optimal and effective immune response
Thx JDM, will add: 4-11-17/J.Hutchins, Immune Profiling World-Congress'17
Apr10-12 2017: “Immune Profiling World Congress 2017”, WashDC Part of “World Vaccine Congress Washington 2017” (1 of 8 Co-Conf’s) “The Immune Profiling World Congress USA brings together experts to discuss profiling of the immune system, how using high throughput technologies can aid therapeutic design & treatment strategies in infectious & non-infectious diseases, including cancer.” http://www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm 4-11-17/Day1 12:10pm: Dr. Jeff Hutchins (VP/PreClinRes., PPHM) “Increasing the Benefits of Immune Checkpoint Therapies Through Increased Tumor Infiltrating Activated T-Cells” *Expanding the responding population *Sharing pre-clinical & translation data - - - - - - Chair: Dr Alison Deckhut Augustine, Branch Chief Basic Immunology, NIAID/NIH DAY1 SPEAKERS 4-11-17(10): ...Bali Pulendran – Emory ...Dr Masahide Yano - FDA ...Dr Jeff Hutchins – Peregrine ...Dr Ali M. Harandi – Univ. of Gothenburg ...Dr Mahesh Yadav - Genentech ...Giuseppe Del Giudice - GSK Vaccines ...Mark M Davis - Stanford Univ. ...Alessandro Sette - La Jolla Infectious Disease Inst. ...Peter W. Che - Repertoire Genesis, Inc ...Dr Wayne C Koff - Human Vaccines Project, Intl. Aids Vaccine Initative DAY2 SPEAKERS 4-12-17(4): ...Dr Roy Baynes (PD-1 Antibodies) – Merck ...Mr Bruno Gomes - iTeos Therapeutics ...Mr Lei Zheng - Johns Hopkins ...Dr Rakesh Dixit - MedImmune